GAO report reveals gaps in US isolation and quarantine planning
By
Donna Shryer
Jul 30, 2024
A new report from the US Government Accountability Office sheds light on challenges and shortcomings in isolation and quarantine planning during the COVID-19 pandemic.
FDA clears nasal spray for moderate Alzheimer’s disease in first patient
By
Donna Shryer
Jul 16, 2024
Two recent developments in Alzheimer’s disease research offer new hope for patients and their families. Among these, in June, Tiziana Life Sciences received Food and Drug Administration clearance...